$5.20
-0.96-15.53%
At close: Nov 11, 4:00 PM EST
$5.12
-1.03-16.75%
Pre-Market: 4:09 AM EST
YD Bio Ltd
YDESNASDAQ
YD Bio fell 39.2% from $10.12 to $6.15, behind the S&P 500's +12.7%. Its worst day was Oct 22 (−26.5%), and its low came Jul 2 at $1.90.
Nov 13, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
YD Bio closed at its highest level of the year, 52.4% above where the year started.
+10.9% · S&P 500 −0.3%
EPS of $-0.12 was reported on $596,817.00 revenue.
−2.7% · S&P 500 +0.3%
Story events cover the past 12 months · Times ET
YD Bio closed at its lowest level of the year, 81.2% below where the year started.
−17.7% · S&P 500 −0.1%
EPS of $0.09 was reported on $846,501.00 revenue.
+1.8% · S&P 500 −0.7%
YD Bio shares rose 47.7%, while the S&P 500 fell 0.1%.
+47.7%, the year's best day · S&P 500 −0.1%
YD Bio shares fell 26.5%, while the S&P 500 fell 1.2%.
−26.5%, the year's worst day · S&P 500 −1.2%
Where it ended: a close of $6.15 on Nov 11, 2026.
Nothing in the past 12 months.
All YDES analyst actionsNothing in the past 12 months.
All YDES dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for YDES and SPY from Benzinga historical bars. Not investment advice.
